Shigellosis: mass drug therapy in an institutional setting.
D000900:Anti-Bacterial Agents; D001407:Bacillus; D002701:Chloramphenicol; D004403:Dysentery; D004405:Dysentery, Bacillary; D005664:Furazolidone; D006801:Humans; D011500:Protein Synthesis Inhibitors; D013752:Tetracycline
D000900:Anti-Bacterial Agents; D011500:Protein Synthesis Inhibitors; D005664:Furazolidone; D002701:Chloramphenicol; D013752:Tetracycline
CHLORAMPHENICOL; DYSENTERY, BACILLARY; FURAZOLIDONE; TETRACYCLINE